Association of enhanced activity of indoleamine 2,3-dioxygenase in dendritic cells with the induction of regulatory T cells in chronic hepatitis C infection

[1]  K. Chida,et al.  Increased serum kynurenine/tryptophan ratio correlates with disease progression in lung cancer. , 2010, Lung cancer.

[2]  J. Routy,et al.  Human Activated T Lymphocytes Modulate IDO Expression in Tumors through Th1/Th2 Balance1 , 2009, The Journal of Immunology.

[3]  N. Hayashi,et al.  Enhanced ability of regulatory T cells in chronic hepatitis C patients with persistently normal alanine aminotransferase levels than those with active hepatitis , 2009, Journal of viral hepatitis.

[4]  D. Fuchs,et al.  Interferon-gamma-triggered indoleamine 2,3-dioxygenase competence in human monocyte-derived dendritic cells induces regulatory activity in allogeneic T cells. , 2009, Blood.

[5]  Kathy O. Lui,et al.  Infectious tolerance via the consumption of essential amino acids and mTOR signaling , 2009, Proceedings of the National Academy of Sciences.

[6]  D. Munn,et al.  The Indoleamine 2,3-Dioxygenase Pathway Is Essential for Human Plasmacytoid Dendritic Cell-Induced Adaptive T Regulatory Cell Generation. , 2007 .

[7]  B. Prabhakar,et al.  Enhanced Engagement of CTLA-4 Induces Antigen-Specific CD4+CD25+Foxp3+ and CD4+CD25− TGF-β1+ Adaptive Regulatory T Cells1 , 2007, The Journal of Immunology.

[8]  C. Brosnan,et al.  Astrocyte Indoleamine 2,3-Dioxygenase Is Induced by the TLR3 Ligand Poly(I:C): Mechanism of Induction and Role in Antiviral Response , 2007, Journal of Virology.

[9]  D. Fuchs,et al.  HIV inhibits CD4+ T-cell proliferation by inducing indoleamine 2,3-dioxygenase in plasmacytoid dendritic cells. , 2007, Blood.

[10]  Jun Sik Lee,et al.  Differential regulation of indoleamine 2,3‐dioxygenase by lipopolysaccharide and interferon gamma in murine bone marrow derived dendritic cells , 2007, FEBS letters.

[11]  P. Puccetti.  On watching the watchers: IDO and type I/II IFN , 2007, European journal of immunology.

[12]  U. Hainz,et al.  The role of indoleamine 2,3‐dioxygenase in transplantation , 2007, Transplant international : official journal of the European Society for Organ Transplantation.

[13]  J. Heeney,et al.  Upregulation of Indoleamine 2,3-Dioxygenase in Hepatitis C Virus Infection , 2007, Journal of Virology.

[14]  N. Hayashi,et al.  Reduced expression and functional impairment of Toll-like receptor 2 on dendritic cells in chronic hepatitis C virus infection. , 2006, Hepatology research : the official journal of the Japan Society of Hepatology.

[15]  M. Takemura,et al.  The signal transducer and activator of transcription 1alpha and interferon regulatory factor 1 are not essential for the induction of indoleamine 2,3-dioxygenase by lipopolysaccharide: involvement of p38 mitogen-activated protein kinase and nuclear factor-kappaB pathways, and synergistic effect of s , 2006, Journal of biochemistry.

[16]  Michael Platten,et al.  Treatment of Autoimmune Neuroinflammation with a Synthetic Tryptophan Metabolite , 2005, Science.

[17]  M. Albert,et al.  A two-step induction of indoleamine 2,3 dioxygenase (IDO) activity during dendritic-cell maturation. , 2005, Blood.

[18]  B. Baban,et al.  GCN2 kinase in T cells mediates proliferative arrest and anergy induction in response to indoleamine 2,3-dioxygenase. , 2005, Immunity.

[19]  S. Archer.  An immunomodulatory role for CD4~+ CD25~+ regulatory T lymphocytes in hepatitis C virus infection , 2005 .

[20]  N. Hayashi,et al.  Reduced numbers and impaired ability of myeloid and plasmacytoid dendritic cells to polarize T helper cells in chronic hepatitis C virus infection. , 2004, The Journal of infectious diseases.

[21]  D. Munn,et al.  Ido expression by dendritic cells: tolerance and tryptophan catabolism , 2004, Nature Reviews Immunology.

[22]  N. Horiike,et al.  Decreased interferon‐α production and impaired T helper 1 polarization by dendritic cells from patients with chronic hepatitis C , 2004, Clinical and experimental immunology.

[23]  S. Sakaguchi.  Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses. , 2004, Annual review of immunology.

[24]  N. Horiike,et al.  Decreased interferon-alpha production and impaired T helper 1 polarization by dendritic cells from patients with chronic hepatitis C. , 2004, Clinical and Experimental Immunology.

[25]  Michel C Nussenzweig,et al.  Tolerogenic dendritic cells. , 2003, Annual review of immunology.

[26]  C. Uyttenhove,et al.  Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase , 2003, Nature Medicine.

[27]  L. Seeff,et al.  Natural history of chronic hepatitis C , 2002, Hepatology.

[28]  D. Keskin,et al.  Potential Regulatory Function of Human Dendritic Cells Expressing Indoleamine 2,3-Dioxygenase , 2002, Science.

[29]  Gerhard Opelz,et al.  Inhibition of Allogeneic T Cell Proliferation by Indoleamine 2,3-Dioxygenase–expressing Dendritic Cells , 2002, The Journal of experimental medicine.

[30]  M. Seishima,et al.  Lipopolysaccharide induction of indoleamine 2,3‐dioxygenase is mediated dominantly by an IFN‐γ‐independent mechanism , 2001, European journal of immunology.

[31]  B. Walker,et al.  Hepatitis C virus infection. , 2001, The New England journal of medicine.

[32]  F. Zoulim,et al.  Impaired allostimulatory function of dendritic cells in chronic hepatitis C infection. , 2001, Gastroenterology.

[33]  N. Hayashi,et al.  Impaired allostimulatory capacity of peripheral blood dendritic cells recovered from hepatitis C virus-infected individuals. , 1999, Journal of immunology.

[34]  D. Munn,et al.  Prevention of allogeneic fetal rejection by tryptophan catabolism. , 1998, Science.

[35]  R. Steinman,et al.  Dendritic cells and the control of immunity , 1998, Nature.

[36]  Milton W. Taylor,et al.  Relationship between interferon‐γ, indoleamine 2,3‐dioxygenase, and tryptophan catabolism , 1991, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[37]  O. Hayaishi,et al.  Tryptophan degradation in mice initiated by indoleamine 2,3-dioxygenase. , 1986, The Journal of biological chemistry.

[38]  O. Takikawa,et al.  Human indolylamine 2,3-dioxygenase. Its tissue distribution, and characterization of the placental enzyme. , 1985, The Biochemical journal.